Dante Solid Tumor Truesight Oncology 500 Sequencing Service for Research
- Principle 500 genes responsible for the tumor appearance
- Specific information about the tumor mutations
- Patient details to verify the reaction to modern treatments
- Next Generation Sequencing methods
Having a clear vision in advance of the patient's reaction to modern treatments, less aggressive and risky than chemotherapies; to study and formulate new drugs and treatments or to learn more about the genetic mutations responsible for the tumor. These are some of the applications of Solid Tumor WES (Whole Exome Sequencing).
The Solid Tumor Sequencing Test (500 genes) analyzes the DNA of cancer cells to extract information on the top 500 genes most responsible for the appearance of the tumor. Thanks to this analysis it is possible to investigate both the patient's genetic mutations and their suitability for a modern therapy, and to collect in-depth information on the tumor to evaluate a molecular target for a new therapy.
The Turnaround Time starts from when your sample is received at the lab. Our labs process samples from Monday to Friday.